AI Article Synopsis
- * Some treatments for prostate cancer can exacerbate depression symptoms, like anhedonia and erectile dysfunction.
- * To address depression effectively, clinicians should adopt a multi-symptom assessment approach tailored to individual patients, including regular screening and diagnosis as part of standard practice.
Article Abstract
Many patients with prostate cancer experience severe levels of depression, which can negatively affect their treatment and disease course. Some prostate cancer treatments can increase the severity of a patient's depression, for example, by increasing anhedonia and erectile dysfunction. Depression is often thought of as a unitary phenomenon, but multiple subtypes can be distinguished. This variety of manifestations challenges the successful application of universal antidepressant treatment options and argues for a multi-symptom assessment process that considers a patient's disease burden and their particular form of depression. Inclusion of screening and detailed diagnosis of depression can be argued to be part of good practice, and clinicians are urged to consider when and how this might be accomplished within their urological practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41585-020-0354-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!